Skip to content

    SUDARSHAN PHARMA INDUSTRIES LIMITED

    Overview

    Price

    Market Cap

    ₹722 Cr

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital1010102424242424
    Reserves1013207788107116131
    Borrowings21303134105171219285
    Other Liabilities1847779767100148202
    Total Liabilities5899138232283402507642
    AssetsFixed Assets66620262453104
    CWIP001026283
    Investments00012143020
    Other Assets5393131200242342424534
    Total Assets5899138232283402507642

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating13-4-29635-2
    Cash from Investing-3-1-1-26-5-20-78
    Cash from Financing0-1466-12-1479
    SummaryCapital Expenditure
    Free Cash Flow-41-5-43230-51
    FCF Margin

    Valuation

    Cyclical, with too little history

    This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.

    SUDARSHAN · CYCLICAL_UNMODELABLE

    Learn to analyse SUDARSHAN PHARMA INDUSTRIES LIMITED

    Guides on how to read this kind of business and the numbers that matter.